Event Details
In-person event details
Additional Information: Due to the expected popularity of this event early booking is advised. Physical spaces for this meeting are limited and will be allocated on a first come, first served basis.
Agenda
Meet the Speakers
Dr Johnson is passionate about providing multidisciplinary diagnostic assessment and management to children and young people suspected of living with neurodisabilities. She has extensive clinical, teaching, managerial and research experience. She holds various roles in undergraduate and postgraduate medical education including, as a personal tutor, examiner, supervisor and Advance Clinical Phase Lead at the University of Nottingham.
Dr Johnson has a proven record of interpersonal and leadership skills coupled with achievements which span throughout her career. She has won clinical excellence awards and was recently nominated for the United Lincolnshire Hospitals NHS Trust Staff Awards in recognition for her hard work and dedication to patient care. Dr Johnson is also an author who enjoys travelling and contributing to her community.
Dr Imad Ahmed is a consultant in Paediatric Respiratory and Sleep Medicine at University Hospitals of Leicester. His subspeciality interests include sleep medicine, long-term ventilation, and cystic fibrosis.
In addition to his clinical role, Dr Ahmed has a strong interest in medical leadership and service transformation. He is a board member of the International Paediatric Sleep Association (IPSA), co-chair of the Midlands Sleep Group and serves as the Children and Young People Clinical Lead at the Leicester, Leicestershire and Rutland Integrated Care Board.
His research interests focus on paediatric sleep apnoea, non-respiratory sleep disorders, and cardiopulmonary exercise testing in children. His main research areas include sleep diagnostics for children, sleep in neurodevelopmental disorders, and clinical outcomes in children on long-term ventilation.
Dr Bleakley is a Neurodisability Paediatrician employed at Sheffield Children’s Hospital NHS Foundation Trust and serves as the Trust Lead for ADHD. With over 25 years of experience, she has developed a passionate and dedicated interest in supporting children, young people, and adults with ADHD, recognising it as a unique opportunity to change lives.
A strong advocate for “measurement-based care,” Dr Bleakley emphasises the importance of using structured outcome measures throughout the medical management and titration of ADHD medication, ensuring that individuals achieve a state of being “fully stable and optimised.”
Dr Bleakley is deeply interested in the evolving science of ADHD, particularly the connections between the brain and body, and is committed to bringing this science to life by sharing new insights and learning.
In addition to leading on ADHD, Dr Bleakley delivers tertiary clinics for holistic assessment, understanding, and management of children and young people with complex needs, including those with significant mental health, physical health challenges, or multiple coexisting conditions.
As a keen educator, Dr Bleakley also works with a large independent lifespan ADHD organisation as an external medical supervisor. Having benefited greatly from the mentorship of an inspirational Neurodisability Paediatrician, the founder of the Sheffield ADHD service, Dr Bleakley is dedicated to passing this learning forward and inspiring others in the same way.
Dr Roy is an Associate Specialist at Birmingham Community Healthcare NHS Foundation Trust, where she has worked for the past 20 years. Based in the north area of Birmingham, Dr Roy serves as the local lead for ADHD, an area of special professional interest.
She runs a weekly new and follow-up ADHD clinic and works closely with the dedicated ADHD nurse service to provide comprehensive assessment and ongoing care for individuals with ADHD.
Emma is a Paediatric Nurse with over 20 years of experience across emergency and inpatient/community setting.
In 2023, she transitioned to a specialist role within substance misuse as a senior nurse, supporting young people under 18 who are affected by drug and alcohol use and gained her non-medical prescribing qualification.
Her work focuses on early intervention, education, and safeguarding. Emma has a special interest in neurodiversity and self-medication with illicit drugs. Her work is driven by a deep passion for making a positive impact and embracing the unique challenges and rewards of engaging with young people in meaningful, transformative ways.
Dr McCloskey is a registered pharmacist of the GPhC and PSNI with a range of experience working across the three main sectors of pharmacy- clinical practice, academia and industry. Upon successful completion of her pre-registration training, Dr McCloskey returned to Queen's University Belfast and completed a PhD in pharmaceutics where she developed 'Self-assembled Peptide Nanomaterials for the Prevention of Biomaterial Infection.'
This was followed by an industry-academia collaborative post-doc between the Royal College of Surgeons in Ireland (RCSI, Dublin) and the Galway-based nebuliser company Aerogen, a global leader in aerosol delivery. This work was also linked with a national patient focused medical device research centre, CURAM based at The National University of Ireland, Galway. Dr McCloskey is a member of the Royal Pharmaceutical Society and Fellow of HEA (Higher Education Academy). Links are maintained with clinical pharmacy through regular days in practice both in hospital and community settings
What will the event cover?
Key learning objectives
- To explore a range of approaches for the effective management of sleep difficulties in young people with neurodevelopmental disorders.
- To provide an understanding of ADHD to better identify, manage, and advocate for individuals with ADHD across the lifespan.
- To gain insights into the treatment of ADHD, including the management of common coexisting conditions.
- To review best practices for addressing substance use, including drug and alcohol-related issues, in young people with neurodiversity.
- To investigate the acceptability of swallowing tablets in children.



